Asmatab 5mg

Tablet
Montelukast Sodium
Veritas Pharmaceuticals Ltd

Other Strength:
- Asmatab 10mg

Alternative:
- Montene 5mg
- Aeron FT 5mg
- M-Lucas 5mg
- Reversair 5mg
- Monalast 5mg
- Provair 5mg
- Montril 5mg
- Monteluk 5mg
- Mon 5mg
- Monas 5mg



Asmatab
Composition
Asmatab: Each tablet contains Montelukast Sodium INN equivalent to Montelukast 10 mg.

Indication
Montelukast is indicated for the prophylaxis and chronic treatment of asthma in adults and pediatric patients 12 months of age and older. It is indicated for prevention of exercise-induced bronchoconstriction (EIB) in patients 15 years of age and older.
It is also indicated for the relief of symptoms of seasonal allergic rhinitis in patients 2 years of age and older and perennial allergic rhinitis in adult patients.

Dosage & Administration
Asthma- For adults and adolescents 15 years of age and older: One 10 mg tablet. Safety and effectiveness in pediatric patients less than 12 months of age with asthma have not been established.
Exercise-Induced Bronchoconstriction (EIB)-For prevention of EIB, a single dose of Montelukast should be taken at least 2 hours before exercise. The recommended dose for adults and adolescents 15 years of age and older is one 10-mg tablet.
Allergic Rhinitis-The recommended dose for the treatment of symptoms of seasonal allergic rhinitis is for adults and adolescents 15 years of age and older: One 10 mg tablet.
Safety and effectiveness in pediatric patients younger than 2 years of age with seasonal allergic rhinitis have not been established.
The recommended dose for the treatment of symptoms of perennial allergic rhinitis is for adults and adolescents 15 years of age and older: One 10 mg tablet.
Safety and effectiveness in pediatric patients younger than 6 months of age with perennial allergic rhinitis have not been established.
Asthma and allergic rhinitis- Patients with both asthma and allergic rhinitis should take only one Montelukast dose daily in the evening.






এই পাতাটি ১৮৮ বার দেখা হয়েছে